ELAVL2, ELAV like RNA binding protein 2, 1993

N. diseases: 199; N. variants: 9
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0005695
Disease: Bladder Neoplasm
Bladder Neoplasm
0.080 Biomarker disease BEFREE A gene-set enrichment analysis (GSEA) revealed that the real hub genes were mainly enriched in "bladder cancer" and "cell cycle" pathways. 31681575 2019
CUI: C0005695
Disease: Bladder Neoplasm
Bladder Neoplasm
0.080 Biomarker disease BEFREE In conclusion, this study indicates that four hub genes have great predictive value for the prognosis of BC, and may contribute to the exploration of the further and more in-depth research of BC. 30927274 2019
CUI: C0005695
Disease: Bladder Neoplasm
Bladder Neoplasm
0.080 Biomarker disease BEFREE Finally, the hub genes in the networks were shown to be valuable candidates as biomarkers for the early stage diagnosis of BC. 31182759 2019
CUI: C0005695
Disease: Bladder Neoplasm
Bladder Neoplasm
0.080 AlteredExpression disease BEFREE The OncoLnc online tool was utilized to analyze the relationship between the expression of hub genes and the prognosis of bladder cancer. 30533316 2018
CUI: C0005695
Disease: Bladder Neoplasm
Bladder Neoplasm
0.080 AlteredExpression disease BEFREE The hub gene expression in BC tissues was validated using reverse transcription-quantitative polymerase chain reaction (RT-qPCR) and western blotting. 28693282 2017
CUI: C0005695
Disease: Bladder Neoplasm
Bladder Neoplasm
0.080 Biomarker disease BEFREE Survival analyses were conducted to characterize the role of hub genes on the survival of BC patients. 29234286 2017
CUI: C0005695
Disease: Bladder Neoplasm
Bladder Neoplasm
0.080 Biomarker disease BEFREE Through data-mining analysis related to putative effect of the identified HUB nodes on survival we identified genes/proteins and their mutations on which it will be useful to focus further experimental studies related to the evaluation of their expression in biological matrices and to their utility as biomarkers of BC development. 29029427 2017
CUI: C0005695
Disease: Bladder Neoplasm
Bladder Neoplasm
0.080 GeneticVariation disease BEFREE ASSET analyses identified four SNPs significantly associated with multiple cancers: rs3731239 (CDKN2A intronic) with ESCC, GC and BC (P = 3.96 × 10(-) (4)); rs10811474 (3' of IFNW1) with RCC and BrC (P = 0.001); rs12683422 (LINGO2 intronic) with RCC and BC (P = 5.93 × 10(-) (4)) and rs10511729 (3' of ELAVL2) with LC and BrC (P = 8.63 × 10(-) (4)). 25239644 2014